Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02342626
What this trial is testing

Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer

Who this might be right for
Adenocarcinoma of Prostate
University of Rochester 140
Testing effectiveness (Phase 2)Study completedNCT00427999
What this trial is testing

Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 67
Testing effectiveness (Phase 2)Study completedNCT02499848
What this trial is testing

Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sophiris Bio Corp 18
Not applicableEnded earlyNCT03740191
What this trial is testing

Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Low Risk Prostate CancerIntermediate Risk Prostate Cancer
EBG MedAustron GmbH 5
Not applicableUnknownNCT05940415
What this trial is testing

Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 220
Testing effectiveness (Phase 2)Study completedNCT03828838
What this trial is testing

Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer

Who this might be right for
Prostate Neoplasm
Radboud University Medical Center 10
Not applicableStudy completedNCT02361515
What this trial is testing

Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid

Who this might be right for
Prostatic Adenocarcinoma
Hospices Civils de Lyon 96
Not applicableLooking for participantsNCT06027892
What this trial is testing

Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

Who this might be right for
PROSTATE CANCER
Rabin Medical Center 562
Early research (Phase 1)Ended earlyNCT05369000
What this trial is testing

Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Lava Therapeutics 96
Not applicableStudy completedNCT00798876
What this trial is testing

Low-Fat Fish Oil Diet for Prostate Cancer Prevention

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 56
Post-approval studies (Phase 4)Looking for participantsNCT06784986
What this trial is testing

Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study.

Who this might be right for
Prostate CarcinomaProstate NeoplasmPain Intensity Assessment+1 more
Brazilian Institute of Robotic Surgery 200
Large-scale testing (Phase 3)Study completedNCT00003674
What this trial is testing

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Alliance for Clinical Trials in Oncology 141
Testing effectiveness (Phase 2)Study completedNCT02628041
What this trial is testing

HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Not applicableLooking for participantsNCT07348367
What this trial is testing

A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.

Who this might be right for
Prostatectomy
Henry Ford Health System 160
Not applicableLooking for participantsNCT06915909
What this trial is testing

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer (Post Prostatectomy)Prostate Cancer Surgery+3 more
East and North Hertfordshire NHS Trust 100
Not applicableNot Yet RecruitingNCT07475533
What this trial is testing

Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy

Who this might be right for
Prostate CancerAnesthesiaRespiratory Mechanics
Ankara City Hospital Bilkent 70
Not applicableLooking for participantsNCT05832736
What this trial is testing

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer

Who this might be right for
Prostate Cancer
Fondazione del Piemonte per l'Oncologia 36
Large-scale testing (Phase 3)Study completedNCT02615067
What this trial is testing

Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer

Who this might be right for
Prostate Cancer
Molecular Insight Pharmaceuticals, Inc. 531
Testing effectiveness (Phase 2)Active Not RecruitingNCT07117760
What this trial is testing

Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
First Affiliated Hospital of Fujian Medical University 16
Not applicableActive Not RecruitingNCT01352429
What this trial is testing

Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Abramson Cancer Center at Penn Medicine 303
Next Page